Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1993 May;84(5):489–492. doi: 10.1111/j.1349-7006.1993.tb00164.x

Enhancement of Reversing Effect of Cyclosporin A on Vincristine Resistance by Anti‐P‐glycoprotein Monoclonal Antibody MRK‐16

Mikihiko Naito 1, Harumi Tsuge 1, Chie Kuroko 1, Akihiro Tomida 1, Takashi Tsuruo 1,2,
PMCID: PMC5919166  PMID: 8100562

Abstract

The synergistic effect of MRK‐16, a monoclonal antibody against P‐glycoprotein, and cyclosporin A (CsA) on the modulation of vincristine resistance was studied by isobologram analysis in three different, highly multidrug‐rcsistant tumor cells. In all cell lines, the synergistic effect was demonstrated at various concentrations of MRK‐16 and CsA. While MRK‐16 alone did not enhance the sensitivity of the moderately resistant KB‐8–5 cells to vincristine, it increased two‐fold the reversing effect of cyclosporin A at 1 μM, an achievable blood concentration. Since MRK‐16 alone showed therapeutic effects against multidrug‐resistant tumors, the combined use of MRK‐16, CsA and antitumor agents should provide therapeutic benefits for the treatment of resistant tumors.

Keywords: VCR resistance, MRK‐16, Cyclosporin A

Full Text

The Full Text of this article is available as a PDF (220.2 KB).

REFERENCES

  • 1. ) Endicott , J. A. and Ling , V.The biochemistry of P‐glycoprotein‐mediated multidrug resistance , Annu. Rev. Biochem. , 58 , 137 – 171 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Pastan , I. and Gottesman , M. M.Multiple‐drug resistance in human cancer . N. Engl. J. Med. , 316 , 1388 – 1393 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Tsuruo , T.Mechanisms of multidrug resistance and implications for therapy . Jpn. J. Cancer Res. , 79 , 285 – 296 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Slater , L. M. , Sweet , P. , Stupecky , M. and Gupta , S.Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro . J. Clin. Invest. , 77 , 1405 – 1408 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Slater , L. M. , Sweet , P. , Stupecky , M. , Wetzel , M. W. and Gupta , S.Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma . Br. J. Cancer , 54 , 235 – 238 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Naito , M. and Tsuruo , T.Competitive inhibition by verapamil of ATP‐dependent high affinity vincristine binding to the plasma membrane of multidrug‐resistant K562 cells without calcium ion involvement . Cancer Res. , 49 , 1452 – 1455 ( 1989. ). [PubMed] [Google Scholar]
  • 7. ) Tamai , I. and Safa , A. R.Competitive interaction of cyclosporins with the Vinca alkaloid‐binding site of P‐glycoprotein in muttidug‐resistant cells . J. Biol Chem. , 265 , 16509 – 16513 ( 1990. ). [PubMed] [Google Scholar]
  • 8. ) Sonneveld , P. , Durie , B. G. M. , Lokhorst , H. M. , Marie , J. P. , Solbu , G. , Suciu , S. , Zittoun , R. , Lowenberg , B. and Nooter , K.Modulation of multidrug‐resistant multiple myeloma by Cyclosporin . Lancet , 340 , 255 – 259 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Hamada , H. and Tsuruo , T.Functional role for the 170‐ to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Naito , M. , Tsuge , H. , Kuroko , C. , Koyama , T. , Tomida , A. , Tatsuta , T. , Heike , Y. and Tsuruo , T.Enhancement of cellular accumulation of Cyclosporin A by anti‐P‐glycoprotein monoclonal antibody MRK‐16, and their synergistic modulation of multidrug resistance . J. Natl. Cancer Inst. , 85 , 311 – 316 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Akiyama , S. , Fojo , A. , Hanover , J. A. , Pastan , I. and Gottesman , M. M.Isolation and genetic characterization of human KB cell lines resistant to multiple drugs . Somatic Cell Mol. Genet. , 11 , 117 – 126 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Steel , G. G. and Peckman , M. J.Exploitable mechanism in combined radiotherapy‐chemotherapy: the concept of additivity . Int. J, Radiat. Oncol , 5 , 85 – 91 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Kano , Y. , Ohnuma , T. , Okano , T. and Holland , J. F.Effect of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture . Cancer Res. , 48 , 351 – 356 ( 1988. ). [PubMed] [Google Scholar]
  • 14. ) Tomida , A. and Suzuki , H.Synergistic effect in culture of bleomycin‐group antibiotics and N‐solanesyl‐N, N'‐bis(3,4‐dimethoxybenzyl)ethylenediamine, a synthetic isoprenoid . Jpn. J. Cancer Res. , 81 , 1184 – 1190 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Ishida , Y. , Shimada , Y. and Shimoyama , M.Synergistic effect of Cyclosporin A and verapamil in overcoming vincristine resistance of multidrug‐resistant cultured human leukemia cells . Jpn. J. Cancer Res. , 81 , 834 – 841 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Rogan , A. M. , Hamilton , T. C. , Young , R. C. , Klecker , R. W. , Jr. and Ozols , R. F.Reversal of Adriamycin resistance by verapamil in human ovarian cancer . Science , 224 , 994 – 996 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Oh‐hara , T. , Hamada , H. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones . Jpn. J. Cancer Res. , 77 , 682 – 692 ( 1986. ). [PubMed] [Google Scholar]
  • 18. ) Berenbaum , M. C.Criteria for analyzing interactions between biologically active agents . Adv. Cancer Res. , 35 , 269 – 335 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Griffith , B. P. , Hardesty , R. L. , Trento , A. , Lee , A. and Bahnson , H. T.Targeted blood levels of cyclosporine for cardiac transplantation . J. Thorac. Cardiovasc. Surg. , 88 , 952 – 957 ( 1984. ). [PubMed] [Google Scholar]
  • 20. ) Borel , J. F.Pharmacology of cyclosporine (Sandimmune) IV. Pharmacological properties in vivo , Pharmacol. Rev. , 41 , 259 – 371 ( 1989. ). [PubMed] [Google Scholar]
  • 21. ) Heike , Y. , Hamada , H. , Inamura , N. , Sone , S. , Ogura , T. and Tsuruo , T.Monoclonal anti‐P‐glycoprotein antibody‐dependent killing of multidrug‐resistant tumor cells by human mononuclear cells . Jpn. J. Cancer Res. , 81 , 1155 – 1161 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. ) Tsuruo , T. , Hamada , H. , Sato , S. and Heike , Y.Inhibition of multidrug‐resistant human tumor growth in athymic mice by anti‐P‐glycoprotein monoclonal antibodies . Jpn. J. Cancer Res. , 80 , 627 – 631 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES